Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT
- PMID: 8611735
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT
Comment on
-
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.Blood. 1995 Sep 1;86(5):2041-50. Blood. 1995. PMID: 7655033
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
